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Polyamine biosynthesis is critical 
for growth and differentiation of 
the pancreas
Teresa L. Mastracci1,3, Morgan A. Robertson3, Raghavendra G. Mirmira1,2,3 & 
Ryan M. Anderson1,2,3
The pancreas, in most studied vertebrates, is a compound organ with both exocrine and endocrine 
functions. The exocrine compartment makes and secretes digestive enzymes, while the endocrine 
compartment, organized into islets of Langerhans, produces hormones that regulate blood 
glucose. High concentrations of polyamines, which are aliphatic amines, are reported in exocrine 
and endocrine cells, with insulin-producing β cells showing the highest concentrations. We utilized 
zebrafish as a model organism, together with pharmacological inhibition or genetic manipulation, 
to determine how polyamine biosynthesis functions in pancreatic organogenesis. We identified that 
inhibition of polyamine biosynthesis reduces exocrine pancreas and β cell mass, and that these 
reductions are at the level of differentiation. Moreover, we demonstrate that inhibition of ornithine 
decarboxylase (ODC), the rate-limiting enzyme in polyamine biosynthesis, phenocopies inhibition or 
knockdown of the enzyme deoxyhypusine synthase (DHS). These data identify that the pancreatic 
requirement for polyamine biosynthesis is largely mediated through a requirement for spermidine 
for the downstream posttranslational modification of eIF5A by its enzymatic activator DHS, which in 
turn impacts mRNA translation. Altogether, we have uncovered a role for polyamine biosynthesis in 
pancreatic organogenesis and identified that it may be possible to exploit polyamine biosynthesis to 
manipulate pancreatic cell differentiation.
The growth and development of a multicellular organism necessitates the successive differentiation of 
specialized cell types from pools of undifferentiated progenitor cells. This coordinated process ultimately 
results in the specification of tissues composed of distinct cell types that harmonize to produce function-
ing organs; each distinct cell type must pass through several semi-differentiated pluripotent cell popula-
tions between the zygote and mature organism. Deciphering the mechanisms that direct this cell-specific 
differentiation is a key biological question with important ramifications for understanding the pathogen-
esis or treatment of many diseases, including diabetes mellitus.
Diabetes is a syndrome that results from the destruction or dysfunction of the insulin-producing 
β cells in the pancreas1. In all organisms, β cell development begins during embryogenesis. Pancreatic 
progenitor cells are specified in the endoderm following the reception of secreted signals. These secreted 
signals then initiate a cascade of pancreas-specific transcription factors within the pancreatic progeni-
tor cells2. In particular, these progenitor cells first co-express the transcription factors pancreatic and 
duodenal homeobox 1 (Pdx1) and pancreas transcription factor 1a (Ptf1a), and subsequently differen-
tiate into cells composing all pancreatic lineages: exocrine, endocrine and duct cells3–5. However before 
differentiation occurs, the progenitor cells increase in number and spatially organize into an intricate 
epithelial tree; progenitors in the trunk domain upregulate Neurogenin3 (Neurog3) before differenti-
ating into endocrine cells6,7, whereas those in the tip domain express CarboxypeptidaseA (Cpa1) and 
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are first multipotent before becoming pro-acinar cells8. Decades of research have revealed a complex 
transcription factor cascade that drives pancreas cell lineage specification and differentiation2. Many 
laboratories are utilizing this knowledge to create protocols to generate insulin-expressing β -like cells 
in vitro for therapeutic purposes9–15. Although some success has been achieved, our understanding of the 
factors required for β cell development remains incomplete. Clearly looking beyond transcription factor 
regulation is necessary for continued advancement.
Interestingly, high concentrations of polyamines have been reported in both exocrine and endocrine 
pancreatic cells, with the insulin-producing β cell showing the highest concentration among the islet 
cells16,17. Polyamines (putrescine, spermidine, and spermine) are polycationic, low molecular weight ali-
phatic amines that are required for cellular proliferation18. The first step in the biosynthesis of polyamines 
requires the rate-limiting enzyme ornithine decarboxylase (ODC), whose sole function is to catalyze the 
decarboxylation of ornithine to putrescine19. Disruption of the gene encoding ODC (Odc1) results in 
early embryonic lethality in the mouse20. Although Odc1-null blastocysts can be recovered, their devel-
opment beyond embryonic day (E) 3.5 is halted by widespread cellular apoptosis and embryo death20, 
providing clear evidence that polyamine biosynthesis is critical for embryogenesis. Moreover, this early 
requirement for polyamines in embryogenesis has, to date, precluded the study of polyamine biosynthesis 
during pancreatic organogenesis.
In this study, using the versatile zebrafish as a model organism, we demonstrate that although the 
multipotent pancreatic progenitor population appears unchanged in size, altering polyamine biosynthesis 
through pharmacologic inhibition of ODC affects both exocrine cells and β cells at the level of differenti-
ation. In addition, we uncover that this pancreatic requirement for polyamine biosynthesis is connected 
to the process of mRNA translation; inhibition of the downstream enzyme deoxyhypusine synthase 
(DHS), which catalyzes the posttranslational modification of the eukaryotic initiation factor 5A (eIF5A), 
phenocopies the inhibition of polyamine biosynthesis. Ultimately, our study identifies that it may be 
possible to exploit polyamine biosynthesis to manipulate pancreatic cell growth and differentiation.
Results
Inhibition of polyamine biosynthesis alters exocrine pancreas growth. Ornithine decarboxylase 
(Odc1; ODC) is the rate-limiting enzyme required for polyamine biosynthesis. The drug difluoromethy-
lornithine (DFMO; Eflornithine) specifically inhibits ODC thereby inhibiting polyamine biosynthesis21. 
Using protein sequence alignment (ClustalW22), zebrafish (Danio rerio) Odc1 was determined to be 75% 
identical to the mouse (Mus musculus) and human (Homo sapiens) orthologs (Supplementary Fig. S1). 
Thus, we took advantage of transgenic zebrafish lines to analyze how pancreas development was altered 
following pharmacological inhibition of ODC; the use of DFMO bypassed the early embryonic require-
ment for ODC20 and permitted the examination of alterations during organogenesis.
In zebrafish, as in mammals, pancreas development begins with the specification of two separate pan-
creatic buds that merge to become one organ. The progenitor cell field comprising the dorsal pancreatic 
bud specifies only endocrine cells that nucleate the principal islet, with the initial wave of endocrine 
cells clustering by 24 hpf; the progenitors comprising the ventral bud differentiate (after 24 hpf) into both 
endocrine and exocrine cells23. The transcription factor Ptf1a marks early pancreatic progenitor cells and 
later differentiated acinar cells, as well as cells in the retina and hindbrain3,24,25; therefore Tg(ptf1a:gfp) 
transgenic zebrafish embryos were used to determine the effect of DFMO treatment on exocrine pan-
creas development. As outlined in Fig. 1a, Tg(ptf1a:gfp) embryos were collected from in cross matings 
and permitted to develop until 24 hours post fertilization (hpf). At 24 hpf, embryos were bathed in egg 
water containing DFMO. Because ODC is expected to have pleiotropic roles throughout development, 
a dose curve was performed to determine the effective dose of 1% w/v DFMO that resulted in endo-
dermal phenotypes, yet produced minimal death or body truncation at 48 and 72 hpf (Supplementary 
Fig. S2a–c). At 48 hpf, ptf1a:GFP expressing organs were identical between control and DFMO-treated 
embryos; however at 72 hpf, the pancreas was reduced in size (Fig.  1b; Supplementary Fig. S2d). An 
overtly shortened pancreas was apparent in 65% of DFMO-treated embryos (Fig. 1c), and measurement 
of the length of the ptf1a:GFP + pancreatic domain revealed that the exocrine pancreas of DFMO-treated 
embryos was 46% shorter than that of control embryos (Fig. 1d).
To determine if exocrine differentiation occurred in the truncated ptf1a:GFP + pancreatic domain, 
whole mount in situ hybridization (ISH) was performed to assess expression of the trypsin gene (try), 
which is expressed in differentiated exocrine cells. Compared with controls, DFMO-treated embryos at 
72 hpf displayed either a moderate or severe reduction in the trypsin domain, with an uneven or patchy 
pattern of expression (Fig. 1e). In total, 66% of DFMO-treated embryos displayed this reduced trypsin 
expression domain (Fig.  1f), which is nearly identical to the percentage of DFMO-treated embryos 
with phenotypic shortened pancreas (Fig.  1c). Subsequent use of fluorescent whole mount ISH per-
mitted analysis of the specific overlap between the ptf1a:GFP exocrine domain and the differentiated 
trypsin-expressing cells. Whereas control pancreas (72 hpf) showed complete overlap between ptf1a:GFP 
and try (Fig. 1g), only a portion of the shortened ptf1a:GFP pancreas domain expressed try after DFMO 
treatment (Fig. 1h). These data reveal that blocking polyamine biosynthesis by pharmacological inhibi-
tion of ODC blunts the differentiation of acinar cells and impedes exocrine pancreas growth.
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Figure 1. Inhibition of polyamine biosynthesis alters exocrine pancreas development. (a) Drug treatment 
strategy. (b) Whole body and exocrine pancreas phenotype in control and DFMO-treated Tg(ptf1a:gfp) 
embryos at 48 hpf and 72 hpf. (c) The number of fish at 72 hpf with a normal (n = 30) or a shortened 
(n = 45) exocrine pancreas, as observed by expression of ptf1a:GFP. (d) Quantification of exocrine pancreas 
length in control (n = 7) and DFMO-treated (n = 16) Tg(ptf1a:gfp) embryos at 72 hpf (p = 0.0002); this 
represents a 46% difference in exocrine pancreas length. (e) Representative images from in situ hybridization 
for expression of the gene encoding trypsin (try) on control and DFMO-treated embryos at 72 hpf. (f) 
Number of control (n = 24) and DFMO-treated (n = 24) embryos with a normal or reduced trypsin (try) 
expression domain at 72 hpf. Wholemount fluorescent in situ hybridization for trypsin gene expression (try) 
was performed on (g) control and (h) DFMO-treated Tg(ptf1a:gfp) embryos. The corresponding maximum 
intensity projection of try expression in (g’) control and (h’) DFMO-treated Tg(ptf1a:gfp) embryos; the white 
dotted line outlines the ptf1a:GFP + exocrine pancreas domain. r, retina; hb, hindbrain; p, pancreas.
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Exocrine differentiation but not progenitor cell specification is altered by inhibition of poly-
amine biosynthesis. A reduction in overall exocrine pancreas size could be attributable to a decrease 
in the total number of progenitor cells specified in the early pancreatic domain, or impaired prolifer-
ative expansion of the acinar cells that do differentiate from these progenitors. Thus, to determine if 
polyamine depletion altered the initial pancreas progenitor cell pool, Tg(ptf1a:gfp) embryos were treated 
with DFMO from 24 hpf to 33 hpf. This stage (33 hpf) was chosen for analysis because a substantial 
population of undifferentiated ventral pancreas progenitors is present; this population of cells is similar 
to the Cpa1 + multipotent progenitor cells identified in mouse, which give rise to differentiated acinar 
cells8,26. Pancreas progenitor cells co-expressing Pdx1 and ptf1a:GFP were quantitated in control and 
DFMO-treated embryos at 33 hpf (Fig. 2a,b); this analysis determined that the progenitor cell population 
was unaltered between control and DFMO-treated embryos (Fig.  2c). Therefore the ventral pancreas 
progenitor cell pool is not altered by inhibition of polyamine biosynthesis.
We next evaluated EdU incorporation into exocrine cells at 72 hpf to determine if the block in exo-
crine differentiation was associated with altered cellular proliferation. Whereas EdU incorporation was 
apparent in both control and DFMO-treated embryos (Fig. 2d,e), the number of EdU+ /ptf1a:GFP + cells 
was significantly reduced in the latter (Fig. 2f). Therefore, among the population of differentiating exo-
crine cells there is a reduction in proliferation. Together these data indicate strongly that a decrease in 
both differentiation and proliferation contributes to a significant reduction in exocrine pancreas size.
Polyamine depletion alters β cell differentiation but not total endocrine cell specification. 
The zebrafish pancreas, like that of mouse and human, is composed of exocrine cells as well as 
hormone-producing endocrine cells, including glucagon-producing α cells and insulin-producing β cells. 
Given that polyamine levels are elevated in both exocrine and endocrine cells in the pancreas16,17, we 
hypothesized that endocrine development would also be affected following inhibition of polyamine bio-
synthesis. In zebrafish, all nascent endocrine cells express the transcription factor neuronal differentiation 
1 (neurod1) prior to terminal differentiation and hormone expression27. Thus, to investigate the endo-
crine population we utilized the Tg(neurod1:gfp) transgenic line. Tg(neurod1:gfp) embryos were treated 
with DFMO as described above, and total endocrine cell number (neurod1:GFP + cells) (Fig.  2g,h), as 
well as individual populations of α and β cells, was quantitated. Whereas the neurod1:GFP + total endo-
crine cell population (Fig. 2i) and glucagon + α cell population (Fig. 2j; Supplementary Fig. S3a,b) were 
unchanged in DFMO-treated embryos at 72 hpf, the insulin + β cells were reduced in number when 
compared with controls (Fig.  2k; Supplementary Fig. S3c,d). DFMO treatment of double transgenic 
zebrafish embryos (Tg(gcga:gfp);Tg(ins:dsRed)) permitted the subsequent analysis of the insulin/glucagon 
co-expressing cells. Interestingly, the number of insulin/glucagon co-expressing cells was significantly 
increased in DFMO-treated embryos compared with controls (Fig. 2l; Supplementary Fig. S3e,f); how-
ever, alterations in β cell number did not impact overall free glucose levels in DFMO-treated embryos 
as compared with controls (Supplementary Fig. S3g). Taken together these results signify that, similar 
to the pancreas progenitor cells, total endocrine cell number is unaltered when polyamine biosynthesis 
is interrupted; however, the subsequent differentiation of insulin-producing β cells is sensitive to altered 
polyamine biosynthesis. Moreover, the increase in the number of insulin/glucagon co-expressing cells 
together with the reduction in total β cell number suggests that inhibition of polyamine biosynthesis 
impedes the maturation of β cells.
To determine if any of the pancreatic cell alterations that resulted from pharmacological inhibition of 
ODC were reversible, Tg(ptf1a:gfp) embryos were treated with DFMO from 24 hpf to 72 hpf, then washed 
and recovered in fresh egg water for either 24 or 48 hours (Fig. 3a). Quantification identified that at 4 dpf 
and 5 dpf there was a persistent decrease in exocrine pancreas length, as compared with age-matched 
controls (Fig.  3b,c). However, the exocrine pancreas length in embryos that were permitted to recover 
for 2 days (5 dpf) was significantly longer than DFMO-treated embryos at 3 dpf (Fig. 3b,c). In contrast, 
there was no recovery of insulin + β cell number (Fig. 3d). These data suggest that the effects of inhibi-
tion of polyamine biosynthesis on exocrine, but not endocrine, pancreas development are reversible. In 
fact, careful examination of the cytoplasmic compartment of ptf1a:GFP + exocrine cells following two 
days of DFMO withdrawal (5 dpf) identified the presence of zymogen granules, which are characteristic 
of properly differentiated exocrine cells (Fig. 3e).
Spermidine rescues the phenotypic defects caused by ODC inhibition. In light of our find-
ing that polyamine biosynthesis (via Odc1) is essential for pancreatic cell development, we next tested 
whether a specific downstream pathway mediates this requirement. Spermidine is one of the polyamines 
synthesized downstream of the reaction catalyzed by ODC. To determine whether polyamine supple-
mentation could prevent the exocrine pancreas phenotype, we treated Tg(ptf1a:gfp) embryos simulta-
neously with DFMO and spermidine at 24 hpf and analyzed the effects at 72 hpf. A dose titration was 
performed to determine that a dose of 1 mM spermidine produced minimal death or body truncation 
(data not shown). Whereas spermidine alone had no effect on exocrine pancreas length, the combined 
treatment of DFMO and spermidine resulted in a complete rescue of the exocrine pancreas phenotype 
to wildtype length (Fig. 3f). These data suggest that restoration of polyamine levels through the addition 
of spermidine can bypass the inhibitory effect of DFMO on pancreatic cell development.
www.nature.com/scientificreports/
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Figure 2. Exocrine and endocrine cell differentiation but not specification is disrupted by DFMO. 
Representative images of (a) control and (b) DFMO-treated Tg(ptf1a:gfp) embryos stained for Pdx1 
and ptf1a:GFP to identify co-expressing ventral pancreas progenitor cells. (c) Quantification of 
Pdx1+ / ptf1a :GFP + progenitor cells in control (n = 13) and DFMO-treated (n = 13) embryos at 33 hpf 
(p = 0.8823). Representative images of pancreas from (d) control and (e) DFMO-treated Tg(ptf1a:gfp) 
embryos at 72 hpf after EdU incorporation. (f) Quantification of the number of EdU-expressing 
ptf1a:GFP + exocrine cells, normalized to total GFP + cells, in control (n = 14) and DFMO-treated (n = 9) 
embryos (p = 0.0055). Representative images of neurod1:GFP + endocrine (islet) cells in (g) control and 
(h) DFMO-treated Tg(neurod1:gfp) embryos at 72 hpf. (i) Quantitation of the neurod1:GFP + endocrine 
cell population at 72 hpf in control (n = 11) and DFMO-treated (n = 14) embryos (p = 0.1392). Specific 
endocrine cell populations were also quantified, including (j) Glucagon + α cells (n = 19 for both 
groups; p = 0.1168), (k) Insulin + β cells (control n = 25; DFMO n = 18; p = 0.0079), and (l) Insulin+ /
Glucagon + co-expressing cells (control n = 20; DFMO n = 35; p = 0.0282). *p < 0.05, **p < 0.01, 
***p < 0.001; ns, not significant; dp, dorsal pancreas; vp, ventral pancreas.
www.nature.com/scientificreports/
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Figure 3. Withdrawal of DFMO treatment causes partial recovery, and spermidine supplementation 
rescues phenotypic defects. (a) Strategy for DFMO treatment and withdrawal. (b) Representative images of 
control and DFMO-treated Tg(ptf1a:gfp) embryos after 0, 1, or 2 days of DFMO treatment withdrawal; white 
dotted box denotes the location of the pancreas (c) Quantification of exocrine pancreas length in control 
(n = 5) and DFMO-treated (n = 5) Tg(ptf1a:gfp) embryos at 3 dpf (p = 0.001); control (n = 6) and DFMO-
treated (n = 4) Tg(ptf1a:gfp) embryos at 4 dpf (one day after DFMO was removed)(p = 0.0064); control 
(n = 7) and DFMO-treated (n = 6) Tg(ptf1a:gfp) embryos at 5 dpf (two days after DFMO was removed)
(p = 0.0381); a significant increase in exocrine pancreas length was observed between embryos that were 
DFMO-treated compared with DFMO + 2 day withdrawal (p = 0.0226). (d) The insulin + β cell population 
was also quantified for 3 dpf control (n = 5) and DFMO-treated embryos (n = 7) (p < 0.05), as well as 
5 dpf control (n = 8) and DFMO + 2 day withdrawal embryos (n = 6) (p < 0.05); no significant difference 
in β cell number was observed after 2 days of DFMO withdrawal (p = 0.1512). (e) Representative images 
of ptf1a:GFP + exocrine pancreas cells from control and DFMO + 2 day withdrawal (5 dpf) Tg(ptf1a:gfp) 
embryos, illustrating the presence of zymogen granules in the ptf1a:GFP + cells. (f) Quantification of 
exocrine pancreas length in control (n = 12), DFMO-treated (n = 15), spermidine-treated (n = 14), and 
DFMO  + spermidine-treated (n = 20) Tg(ptf1a:gfp) embryos at 72 hpf. Whereas DFMO treatment resulted 
in reduced exocrine pancreas length (p < 0.0001), the exocrine pancreas in embryos treated with spermidine 
alone was longer than DFMO-treated (p < 0.0001) but no different from wildtype (p = 0.1843). DFMO-
treatment supplemented with spermidine showed exocrine pancreas length no different from wildtype 
(p = 0.8176) and significantly longer compared with DFMO-treated embryos (p < 0.0001). dpf, days post 
fertilization; *p < 0.05, **p < 0.01, ***p < 0.001; ns, not significant.
www.nature.com/scientificreports/
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One known role of the polyamine spermidine is that it serves as a substrate for the production of 
the active form of the eukaryotic mRNA translation factor, eIF5A. The posttranslational modification 
of eIF5A, known as “hypusination”, requires spermidine, the enzymes deoxyhypusine synthase (DHS) 
and deoxyhypusine hydroxylase (DHH), and the Lys50 residue of eIF5A (Fig. 4a). Importantly, DHS is 
the rate limiting enzyme catalyzing the addition of hypusine [N(ε ) (4-amino-2-hydroxybutyl)lysine] to 
eIF5A (eIF5AHyp)28–30. This process, and its connection to polyamine biosynthesis, has never been studied 
in the context pancreas development. Interestingly, western blot analysis of control and DFMO-treated 
Figure 4. Expression patterns of dhps and eif5a in zebrafish. (a) Pathway illustrating the connection 
between the polyamine biosynthetic pathway, eIF5A, and DHS. Wholemount in situ hybridization for  
(b) dhps and (c) eif5a at 48 hpf and 72 hpf. At 72 hpf, higher magnification reveals expression of (d) dhps and 
(e) eif5a in the liver, intestine and pancreas. (f) Fluorescent in situ hybridization of eif5a in Tg(neurod1:gfp) 
transgenic fish at 72 hpf confirms expression in endoderm-derived organs, including swim bladder (SWB), 
intestine, liver, and pancreas.
www.nature.com/scientificreports/
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embryos identified no difference in the expression of DHS, but a significant reduction in the expression 
of the hypusinated form of eIF5A (eIF5AHyp)(Supplementary Figure S3h–j), which points to a direct 
connection between polyamine biosynthesis and the downstream process of mRNA translation involving 
eIF5AHyp.
Knockdown of dhps by morpholino phenocopies inhibition of polyamine biosynthesis. To 
further investigate this connection between polyamine biosynthesis and eIF5AHyp-mediated mRNA 
translation, we first examined the embryonic expression of dhps and eif5a and then used a knockdown 
approach to examine pancreas developmental phenotypes in the absence of DHS, the rate-limiting enzyme 
in the process of hypusination. Similar to Odc1, protein sequence alignment (ClustalW22) revealed that 
zebrafish Dhps and Eif5a are 76% and 82% identical, respectively, to their mouse and human orthologs 
(Supplementary Fig. S4). Whole mount ISH analysis identified a similar expression pattern between dhps 
and eif5a in zebrafish embryos (Fig. 4b,c). Moreover, this expression pattern was similar to that of odc1 
(data from the Zebrafish Information Network (ZFIN), University of Oregon, Eugene, OR 97403-5274; 
http://zfin.org/; 12/3/2014). Of particular interest, expression was observed in endoderm-derived organs, 
including the liver, intestine and pancreas (Fig. 4d,e). Higher resolution fluorescent ISH confirmed local-
ization to the endodermal organs at 72 hpf (Fig. 4f). One day earlier (48 hpf), expression in the pancreas 
was also identified, with expression observed in both the exocrine and endocrine compartments (endo-
crine visualized by expression of neurod1:GFP) (Supplementary Fig. S5).
With pancreatic expression of dhps and eif5a confirmed, we next tested the hypothesis that DHS 
lies functionally downstream of ODC by generating a splice-blocking morpholino (MO) to knockdown 
dhps in the developing zebrafish embryo. By design, the MO interrupted splicing of exons 2 and 3, and 
caused a deletion of exon 2 in zygotically transcribed dhps (Fig.  5a). A dose curve was performed to 
determine a partial yet effective dhps knockdown; zygotic injection of 1 ng or 2 ng of dhps MO produced 
an altered phenotype in the pancreas of Tg(ptf1a:gfp) larvae at 72 hpf without significant death or dis-
ruption to overall embryonic development (Supplementary Fig. S6a,b). To confirm efficacy of the dhps 
MO, RT-PCR was performed from control and MO-injected embryos, and subsequent sequencing of the 
PCR product confirmed deletion of exon 2 (Fig. 5b; Supplementary Fig. S6c). Although no overt changes 
were observed in the ptf1a:GFP-expressing retina and hindbrain, the increasing dhps MO doses resulted 
in increasing severity of a truncated pancreas phenotype (Fig. 5c).
Similar to the phenotype observed in DFMO-treated embryos, knockdown of dhps impaired exo-
crine pancreas development. The majority of dhps MO-injected embryos displayed a shortened exocrine 
pancreas (Fig. 6a,b). Measurement of the ptf1a:GFP + exocrine pancreas domain identified a significant 
reduction in pancreas length between control and either 1 ng or 2 ng dhps MO-injected embryos; 2 ng 
dhps MO-injected embryos showed the greatest size reduction with a 45% difference in length compared 
with controls (Fig.  6c). This truncated pancreas phenotype is nearly identical to that observed after 
DFMO-induced inhibition of polyamine biosynthesis (Fig. 1d). To examine exocrine cell differentiation 
in the ptf1a:GFP + pancreatic remnant of dhps MO-injected embryos, whole mount ISH was performed 
for try (Fig.  6d); 42% and 88% of 1 ng and 2 ng dhps MO-injected embryos, respectively, displayed a 
reduced trypsin expression domain at 72 hpf (Fig. 6e). Taken together these data reveal that knockdown 
of dhps closely phenocopies inhibition of ODC, and likely places the action of DHS in the same pathway 
as ODC.
Knockdown of dhps inhibits β cell differentiation. To quantitate the total endocrine cell popu-
lation after knockdown of dhps, we utilized Tg(neurod1:gfp) transgenic zebrafish embryos. As shown in 
Fig. 7a,b, dhps MO-injected embryos displayed no change in the total number of neurod1:GFP + endo-
crine cells. However, similar to DFMO-treated embryos, a significant reduction in the insulin + β cell 
population was observed (Fig. 7c). Using the zebrafish embryo made it possible to also determine the ori-
gin of the β cells that were altered with loss of dhps by performing a label retaining cell (LRC) assay31,32. 
This assay uses H2B-RFP mRNA simultaneously co-injected with the dhps MO to uniformly label all 
early embryonic cells; as development proceeds, quiescent cells retain RFP expression (including dorsal 
pancreas-derived cells) while dividing cells (including ventral pancreas-derived cells) dilute the RFP 
signal (Fig. 7d). The LRC assay indicated that β cells derived earlier, from dorsal pancreatic progenitor 
cells (RFP+ ), were unaltered in number (Fig. 7e) whereas those derived later, from the ventral pancreatic 
progenitor cells (RFP-), were significantly reduced in number (Fig. 7f).
To confirm that loss of DHS alters both exocrine cell and β cell development, Tg(ptf1a:gfp) embryos 
were treated with the DHS inhibitor N1-guanyl-1,7-diaminoheptane (GC7)33 using an experimental 
design identical to that of treatment with DFMO (Fig. 8a). A dose titration was performed to determine 
that a dose of 20mM GC7 resulted in endodermal phenotypes, yet produced minimal death or body 
truncation (data not shown). GC7 treated embryos were analyzed at 72 hpf and displayed a reduced 
ptf1a:GFP + exocrine pancreas domain (Fig. 8b–d), as well as a reduction in the number of insulin + cells 
(Fig.  8b,c,e). These analyses confirm that knockdown of dhps or functional inhibition of DHS, similar 
to inhibition of polyamine biosynthesis by DFMO, results in a reduction of exocrine pancreas and β cell 
mass.
www.nature.com/scientificreports/
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Discussion
Whereas polyamine biosynthesis is known to be important for cellular proliferation and essential for the 
earliest stages of embryonic development, this pathway has never been studied in the context of organ 
development. The zebrafish has many characteristics that make it an ideal model for studying vertebrate 
organogenesis and cell fate determination, including optical transparency, external fertilization, facile 
genetic manipulation, and rapid development. Given that pancreatic organogenesis in zebrafish closely 
approximates the mammalian process, we utilized this model system and, in particular, numerous pan-
creas cell-specific transgenic reporter strains to dissect the function of polyamine biosynthesis in pan-
creatic organogenesis.
Our study determined that inhibiting polyamine biosynthesis does not alter pancreas progenitor 
(Pdx1+ /Ptf1a+ ) cell number; however, the dramatic phenotype observed of a shortened exocrine pan-
creas after treatment with DFMO or knockdown/inhibition of DHS defines a role for polyamines in 
both the proliferation and differentiation of exocrine cells. This expanded function of polyamines in 
the pancreas may permit reinterpretation of previous studies. In particular, DFMO treatment of pan-
creas after chemically-induced (caerulein) injury only implicated altered proliferation as the cause of the 
reduced exocrine pancreas regrowth/regeneration34,35. The results of our study would suggest that DFMO 
treatment altered proliferation as well as the differentiation of exocrine cells from injury-stimulated 
Figure 5. Knockdown of dhps in the developing zebrafish. (a) Design of the dhps splice-blocking 
morpholino (MO). (b) Injection of the dhps MO results in a loss of exon 2, as confirmed by RT-PCR from 
control and MO-injected Tg(ptf1a:gfp) embryos; wildtype dhps, 385 bp; E2 deletion in dhps, 172 bp. (c) dhps 
MO-injected Tg(ptf1a:gfp) embryos at 72 hpf show a significant pancreatic phenotype after low dose MO 
injection (1 ng or 2 ng). E, exon; bp, base pair.
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progenitors36–41. Likewise, genetic models displaying reduced exocrine differentiation, such as the 
pancreas-specific deletion of c-myc42, could possibly be rescued by induction of polyamine biosynthesis.
The embryonic pancreas has a known population of multihormonal insulin/glucagon co-expressing 
endocrine cells. Early lineage tracing studies in mouse refuted the notion that these cells are β cell pro-
genitors43; however, a decade of research and advancements in technology have rekindled the debate. 
Based on more recent evidence in the mouse, it has been proposed that insulin/glucagon co-expressing 
cells reflect a population of cells expressing proglucagon that may serve as β cell precursors (a “pro-α ” 
cell population)44. Likewise evidence from zebrafish points to these multihormonal cells as an immature 
endocrine cell population during development with the potential to give rise to either α or β cells45. In 
Figure 6. Knockdown of dhps inhibits exocrine cell differentiation. (a) Representative images of the 
pancreas from control, 1 ng MO-injected, and 2 ng MO-injected Tg(ptf1a:gfp) embryos; images also depict 
characteristic pancreata with a “moderate” or “severe” defect in exocrine length. (b) The percentage of 
control (n = 20), 1 ng MO-injected (n = 46), and 2 ng MO-injected (n = 23) embryos with a normal or 
shortened exocrine pancreas at 72 hpf, as observed by expression of ptf1a:GFP. (c) Quantification of exocrine 
pancreas length in control (n = 11), 1 ng MO-injected (n = 11), and 2 ng MO-injected (n = 10) embryos 
(p < 0.0001) at 72 hpf; this shows a 45% difference in exocrine pancreas length. (d) Representative images 
of in situ hybridization for try (gene encoding trypsin) on control and MO-injected embryos at 72 hpf. (e) 
The percentage of control (n = 15), 1 ng MO-injected (n = 5), and 2 ng MO-injected (n = 19) embryos with 
normal or reduced expression of trypsin at 72 hpf. MO, morpholino; *p < 0.05, **p < 0.01, ***p < 0.001.
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Figure 7. Knockdown of dhps inhibits β cell differentiation. (a) Representative images of 
neurod1:GFP + endocrine cells in the pancreas of control, 1 ng MO-injected, and 2 ng MO-injected 
Tg(neurod1:gfp) embryos at 72 hpf. Quantification of the number of (b) neurod1:GFP + cells in  
control (n = 15), 1 ng MO-injected (n = 15), and 2 ng MO-injected (n = 13) embryos (p = 0.0783), and 
(c) insulin + β cells in control (n = 8), 1 ng MO-injected (n = 8), and 2 ng MO-injected (n = 8) embryos 
(p = 0.012), at 72 hpf. (d) Representative images of the insulin + β cells from control, 1 ng MO-injected, 
and 2 ng MO-injected Tg(ptf1a:gfp) embryos at 72 hpf after label-retaining cell (LRC) assay was performed. 
LRC + cells express H2B-RFP. Quantification of the number of (e) insulin+ /RFP + cells (LRC + or dorsal 
pancreas-derived cells) in control (n = 8), 1 ng MO-injected (n = 8), and 2 ng MO-injected (n = 8) embryos 
(p = 0.734), and (f) insulin+ /RFP- cells (LRC- or ventral pancreas-derived cells) in control (n = 8), 1 ng 
MO-injected (n = 8), and 2 ng MO-injected (n = 8) embryos (p = 0.0147), at 72 hpf. *p < 0.05, **p < 0.01, 
***p < 0.001; ns, not significant.
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our model, inhibition of polyamine biosynthesis does not alter α cell number but does reduce the β cell 
population and concomitantly increase the number of insulin/glucagon co-expressing cells. These data 
suggest that even when polyamine biosynthesis is inhibited, immature endocrine cells continue differ-
entiating toward the α cell lineage, but that additional signals including increased cellular polyamines 
are required to drive differentiation toward the β cell lineage. This is in concordance with previous 
studies that showed exogenous polyamine supplementation could promote insulin expression46, as well 
as neogenesis of β cells from duct-associated progenitors in the pancreata of rats injured by alloxan 
treatment47. Together, these findings further support the idea that polyamines in the pancreas have an 
alternate cellular function than simply proliferation—these aliphatic amines also function in the process 
of cellular differentiation.
Loss of dhps results in embryonic lethality in mice48. Our study was designed to investigate progres-
sive stages of pancreas development—from the progenitor cell stage through to differentiated exocrine 
and endocrine cells. Moreover, our use of partial knockdowns via morpholino and small molecule inhib-
itors permitted the evaluation of specific aspects of pancreas development at specific stages. We used a 
splice-blocking morpholino with the deliberate intent of generating a delayed knockdown by only dis-
rupting zygotic zebrafish dhps. We exploited this aspect of splice-blocking morpholino design to permit 
normal development in the earliest embryonic stages, due to maternally contributed dhps expression, 
but knockdown of dhps during later organogenesis; the resulting experimental embryos had clear dis-
ruption of dhps (Fig. 5; Supplementary Fig. S6). In addition, the combined use of morpholino and LRC 
assay allowed for the evaluation of differentiated endocrine cells derived from two discrete progenitor 
sources. In zebrafish, dorsal pancreas-derived endocrine cells are similar to the “first wave endocrine 
cells” described in the mouse49 whereas ventral pancreas derived endocrine cells are akin to those that 
differentiate during the secondary transition in mouse50. Moreover, there is evidence that these two pools 
Figure 8. Pharmacological inhibition of DHS with GC7 phenocopies genetic loss of dhps and inhibition 
of ODC. (a) Inhibitor treatment strategy. Representative maximum intensity projection images of the 
pancreas from (b) control and (c) GC7-treated Tg(ptf1a:gfp) embryos; for comparison single channel 
images are also provided for ptf1a:GFP expression in (b’) control and (c’) GC7-treated embryos, and insulin 
expression in (b”) control and (c”) GC7-treated embryos. (d) Quantification of exocrine pancreas length in 
control (n = 12) and GC7-treated (n = 15) Tg(ptf1a:gfp) embryos at 72 hpf (p < 0.0001); this represents a 40% 
difference in exocrine pancreas length. (e) Quantification of insulin + β cell number in control (n = 9) and 
GC7-treated (n = 13) Tg(ptf1a:gfp) embryos at 72 hpf (p = 0.0556). *p < 0.05, **p < 0.01, ***p < 0.001.
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of endocrine cells may be functionally different31. Our use of the LRC assay permitted these populations 
to be segregated and evaluated, ultimately determining that inhibition of polyamine biosynthesis alters 
the β cells derived from the later specified ventral pancreas progenitors, which appear to be the popula-
tion of endocrine cells of functional significance to carbohydrate metabolism.
The reduction in β cell number as a result of ODC or DHS inhibition also raises the question of 
whether there is an overall effect on glucose metabolism in embryos where polyamine biosynthesis is 
inhibited. In the mouse, altered glucose homeostasis is observed with near complete β cell loss (e.g. high 
dose streptozotocin treatment), or disruption to the normal function of organs important in maintain-
ing whole body metabolism (e.g. liver, brain). Regrettably many routine analyses in mouse cannot be 
performed in zebrafish embryos; however, we were able to evaluate whole embryo free glucose levels as 
a surrogate measure of metabolic health. Our data demonstrated no change in glucose levels following 
DFMO treatment, which implies that the reduction in β cell number, although statistically significant, is 
not large enough to result in altered glucose homeostasis. Whereas it remains possible that other organs 
important for the maintenance of proper metabolic health are also affected by DFMO treatment, the 
euglycemia observed in DFMO-treated embryos suggests that inhibition of polyamine biosynthesis does 
not disrupt normal glucose metabolism.
In the pursuit of expanding our understanding of how polyamine biosynthesis functions during 
pancreatic organogenesis, we have generated data that support a direct connection between polyamine 
biosynthesis and the downstream process of mRNA translation. Our study showed that inhibition of 
polyamine biosynthesis (with DFMO) reduced expression of the hypusinated form of eIF5A, and that 
the pancreatic phenotype after DFMO treatment was identical to that of dhps knockdown (with MO) and 
DHS inhibition (with GC7). Together, these data constitute strong evidence that these factors function in 
the same pathway. Connecting polyamine biosynthesis with DHS and eIF5AHyp implicates cellular poly-
amines as a requirement for proper mRNA translation. Determining how DHS and eIF5AHyp function in 
the translation of specific mRNAs important for cellular differentiation is currently under investigation.
Although this relationship between polyamine biosynthesis, mRNA translation, and cellular differen-
tiation is in part speculative it underscores the conceptual advance arising from this work. Collectively 
the data presented in this study establishes that polyamine biosynthesis is required for cellular differ-
entiation, and that inhibition of the enzyme ODC or the downstream enzyme DHS negatively impacts 
the differentiation of specific pancreatic cell types. In short, this connection supports the idea that the 
differentiation of cellular lineages, and in particular the pancreatic β cell lineage, might be influenced by 
the exogenous administration of polyamines. Moreover, the simplicity of this particular scheme lends 
itself to be applied to many currently published in vitro differentiation protocols from embryonic stem 
cells12–15. In fact the results of our study would suggest that the application of exogenous polyamines has 
the potential to enhance the yield of in vitro generated insulin-producing β cells for the treatment of 
persons with diabetes, and is therefore an avenue of current investigation.
Methods
Zebrafish (Danio rerio) maintenance and strains. All zebrafish transgenic lines were previously 
published, and raised in standard laboratory conditions at 28.5 °C. The following transgenic lines were 
used in the experiments: Tg(ptf1a:gfp)jh1 51, Tg(neurod1:gfp)52, Tg(gcga:GFP)ia1 26, Tg(ins:dsRed)m1018 53. All 
lines were maintained and used according to the “Guidelines for Use of Zebrafish in the NIH Intramural 
Research Program” (approved 03/11/09 and revised 05/08/13; http://oacu.od.nih.gov/ARAC/documents/
Zebrafish.pdf). All animal procedures were conducted in accordance with OLAW guidelines and were 
approved by the Indiana University Institutional Animal Care and Use Committee.
Pharmacological treatments. Zebrafish embryos were collected and cultured in standard conditions 
at 28.5 °C in egg water supplemented with (4 mM) 1-phenyl 2-thiourea (PTU). Pharmacological inhibi-
tor, 1% w/v difluoromethylornithine (DFMO) (generous gift from Dr. P. Woster) or 20 mM N1-guanyl-
1,7-diaminoheptane (GC7) (ProSpec), was then added to the egg water at 24 hpf, refreshed at 48 hpf, and 
washed out at 72 hpf. The optimal concentration was determined by dose curve, using GFP expression in 
Tg(ptf1a:gfp) embryos as the phenotypic read out, examining embryos for alterations in proper pancreas 
development without gross alteration in overall morphology.
For experiments involving spermidine supplementation, embryos were cultured in egg water with 
1 mM spermidine (Sigma-Aldrich) either alone or in combination with 1% w/v DFMO. The optimal 
concentration of 1 mM spermidine was determined by dose curve examining embryos for alterations in 
overall morphology and viability.
Glucose measurement. Glucose levels in zebrafish embryos were measured using the glucose assay 
kit, as per the manufacturers instructions (Biovision)45.
Microinjection and morpholino design. The following antisense morpholino (MO) (Gene Tools, 
LLC) was injected into 1-cell stage embryos: dhps MO (targeting NM_213222), 5′ - 
ACGATCAGTCTGTCACTCACCATCT (1 ng and 2 ng), targeting the splice site at the junction of exon 
2 and exon 3. H2BRFP mRNA was transcribed with SP6 mMessage machine kit (Invitrogen), and 100 pg 
was co-injected into zygotes along with dhps MO. Efficiency of knockdown was determined by RT-PCR, 
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using primers that amplify across the predicted deletion: 5′ - GCGCTGTGAAATGTGAGTGAAAC and 
5′ - GTTTGACGTGTAGCCCAGGAAT. The resultant PCR amplicon was 385 bp in the control embryos 
and 172 bp in the dhps MO-injected embryos, and was visualized by standard agarose gel electrophoresis.
In situ hybridization and immunofluorescence. Whole mount immunofluorescent staining and 
cell quantifications were performed as previously described53. For immunofluorescence the follow-
ing antibodies were used: chicken anti-GFP (Aves Labs); guinea pig anti-insulin (Biomeda); mouse 
anti-glucagon (Sigma); rabbit anti-dsRed (Clontech); guinea pig anti-Pdx1 (gift of Dr. C. Wright). 
Alexa Fluor-conjugated antibodies were used for visualization (Life Technologies), and DAPI 
(Invitrogen) was used to identify nuclei. For wholemount in situ hybridization, antisense probes 
were transcribed from templates that were generated by PCR from cDNA using primer sets that 
amplify eif5a (5′ -TCCAGATCTTGATTTCGCCAG and 5′ -GGAGGTTGAGGTGGGGTAA) or dhps 
(5′ -GCCTCTGCCGGACAATCT and 5′ -CTGCACTGGAAGGCAATGAA). BM purple (Roche Life 
Sciences), Vector Red (Vector Laboratories), or Fast Red (Sigma-Aldrich) was used for visualization. For 
Z-stack images and cell quantification, embryos were imaged using an LSM 700 confocal microscope 
(Zeiss). Whole body embryo images were captured with a M205 FA wholemount epifluorescence micro-
scope (Leica). Cell number quantification and pancreas length measurements were performed using 
ImageJ software54.
Western blot analysis. Cell lysate from whole embryos was prepared by homogenization (Polytron 
PT2100) in lysis buffer (50 mM Tris (pH 8.0), 150 mM NaCl, 0.05% Desoxycholate, 0.1% IGEPAL, 
0.1% SDS, 0.2% sarcosyl, 10% glycerol, 1 mM DTT, 1mM EDTA, 10 mM Na, protease inhibitors (com-
plete Mini, EDTA-free, Roche), phosphatase inhibitors (PhosStop, Roche), 2 mM MgCl2, 0.05% v/v 
Benzonase) followed by western blot analysis. The antibodies used for detection of protein include 
mouse anti-deoxyhypusine synthase (Santa Cruz), rabbit anti-eIF5AHyp30, and rabbit anti-Erk1/2 (Cell 
Signaling). IRDye and VRDye conjugated secondary antibodies were used for visualization (LI-COR).
Proliferation assay. 5-ethynyl-2′-deoxyuridine (EdU) was injected into each embryo at 72 hpf by 
cardiac puncture using a microinjector (Toohey Company). EdU was permitted to incorporate into DNA 
for 30 minutes. The Click-iT EdU Alexa Fluor 647 Imaging Kit (Invitrogen) was used to detect EdU. 
Embryos were counterstained with DAPI and whole pancreas Z-stack images were obtained using a 
LSM 700 confocal microscope (Zeiss). The percentage of proliferating cells was determined by evaluating 
the number of EdU+ /GFP + cells as a function of the total number of GFP + cells at the midline of the 
pancreas.
Statistical analysis. Data are presented as the mean ± SEM. One-way ANOVA with Tukey’s Multiple 
Comparison Test was used for comparisons involving more than two conditions, and a two-tailed Student 
t test was used for comparisons involving two conditions. In all cases, significance was indicated on the 
graph as follows: p ≤ 0.05 (*), p ≤ 0.01 (**), p ≤ 0.001 (***). Prism5 software (GraphPad) was used for 
all statistical analyses.
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